Study Provides Preliminary Evidence in Favor of a New Type 1 Diabetes Treatment
Researchers have discovered preliminary evidence for a new type 1 diabetes treatment using the drug DFMO, supplied by UF startup Panbela Therapeutics.
UF Startup RedoxBlox Receives Funding From California Energy Commission as Part of Long-Duration Energy Storage Project
UF startup RedoxBlox recently received $8,936,778 in funding from the California Energy Commission aimed at improving resilience and reliability among low-income and disadvantaged communities.
Oragenics, Inc. Announces Private Placement
Oragenics, a UF startup, is partnering with healthcare investors. They've privately placed 404,728 shares of common stock and 404,728 shares of Series E Mirroring Preferred Stock to fight infectious diseases, including coronaviruses.
UF Startup and Innovate Accelerate Resident, Micro Nano Technologies, Receives DOE Recognition in $135M Emission Reduction Campaign
DOE Awards $135M to 40 Projects Driving US Industrial Sector Decarbonization, Including UF Startup 'Micro Nano Technologies,' in Pursuit of Nationwide Net-Zero Emissions Economy by 2050.
UF Startups Among Companies Selected for U.S. Funding to Reduce Carbon Emissions
UF startup Micro Nano Technologies, incubating at UF Innovate | Accelerate at The Hub, is one of six companies sharing $16.2 million in funding for decarbonizing paper and forest products. The goal is to reduce net energy GHG emissions in the paper and forest products industry including increasing the share of renewable energy used, electrification, carbon capture, and energy efficiency.
Finding Fires With Lightning Speed
To address this urgent problem, Fire Neural Network (FNN), a company based in Gainesville, Florida, is utilizing artificial intelligence (AI) to expedite the identification of devastating wildfires from 24 hours to just 40 seconds.
Glint Pharmaceuticals Receives FDA IND Acceptance for Clinical Study for Phase 1/2 Clinical Trial of Antibiotic Drug-Releasing Contact Lens, ACL5
UF startup Glint Pharmaceuticals (Glint), a clinical-stage biotechnology company focused on developing a next-generation contact lens drug delivery technology, announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate its antibiotic drug delivery contact lens, ACL5. Glint anticipates beginning the investigation in Q2 2023.
A Founder’s Collaboration Skills May Be the Key to Success, Especially in Deep Tech
Accelerators like UF Innovate are crucial to the early-stage economy, and to innovation in the United States. It’s at places like these that new technologies can be brought to the market, including technologies that with a profound effect on people’s lives and health. One UF Innovate company, for instance, is MYOLYN, which makes therapy systems for people with neurological disorders and injuries, like multiple sclerosis or stroke.
Startup Spotlight: Slice Engineering
Imagine 3D printing a body part for a major organ transplant surgery to save a person’s life. The backgrounds of both co-founders, Daniel Barousse and Chris Montgomery, have been influenced by this incredible technology. Their curiosity and insights into creating a better and more dynamic 3D printing experience for their clients were the geneses of UF Innovate | Accelerate client resident, Slice Engineering.
UF/IFAS Helps Floridians Launch Food Business Dreams
After 10 years as an educator, Smith wanted a new adventure.
“I thought of what I enjoyed doing, but none of those things were appealing to me to do as a business,” she said. “Except for making fried lentils. For me, making lentils was very relaxing. Not only that, but everybody loved my lentils. It’s a favorite family snack.”
At first, Smith put the idea on the backburner, thinking it might not be feasible.
“I thought that I would immediately have to get my product in stores, and I had no idea how to do that,” she said. “I didn’t even originally attend the Extension cottage food course with the intention of starting my own business. It was to support someone else. But once there, a lightbulb went off. I realized I could do this.”
